Search

Pharmagest Interactive

Abrir

0

Visão Geral

Variação de preço das ações

24h

Atual

Mín

Máximo

Indicadores-chave

By Trading Economics

Rendimento

19M

Vendas

109M

P/E

Médio do Setor

15.641

Rendimento de Dividendos

2.54

Margem de lucro

17.503

Funcionários

1,271

EBITDA

-62M

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

2.54%

Próximos Ganhos

26 de set. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

734M

Abertura anterior

0

Fecho anterior

0

Pharmagest Interactive Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

27 de ago. de 2025, 22:51 UTC

Ganhos

Wesfarmers Plans Special Payout to Shareholders as Annual Net Profit Rises 14%

27 de ago. de 2025, 23:57 UTC

Ganhos

Trip.com Group 1H Rev $4.01B

27 de ago. de 2025, 23:57 UTC

Ganhos

Trip.com Group 1H Adj EPS $1.84

27 de ago. de 2025, 23:57 UTC

Ganhos

Trip.com Group 1H EPS $1.82

27 de ago. de 2025, 23:50 UTC

Conversa de Mercado

Nikkei May Decline Amid Caution Over Tariff Impact, Chip Demand -- Market Talk

27 de ago. de 2025, 23:39 UTC

Ganhos

Correction to Nvidia Earnings Article -- WSJ

27 de ago. de 2025, 22:59 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

27 de ago. de 2025, 22:59 UTC

Conversa de Mercado

HP CEO Sees Strong Back-to-School Spending on PCs -- Market Talk

27 de ago. de 2025, 22:58 UTC

Ganhos

South32 Records Significant Items of $71 Million Tied to Worsley, Mozal

27 de ago. de 2025, 22:57 UTC

Ganhos

South32 FY Free Cash Flow $192 Million

27 de ago. de 2025, 22:56 UTC

Ganhos

South32 FY Total Capital Expenditure $1.35 Billion

27 de ago. de 2025, 22:56 UTC

Ganhos

South32 FY Capital Expenditure $963 Million, Excluding EAIs

27 de ago. de 2025, 22:55 UTC

Ganhos

South32 Net Cash $123 Million at June 30

27 de ago. de 2025, 22:54 UTC

Ganhos

South32: Focused on Maintaining Strong Operating Momentum

27 de ago. de 2025, 22:53 UTC

Ganhos

South32: $144 Million Remains to be Returned to Shareholders Under Program

27 de ago. de 2025, 22:53 UTC

Ganhos

South32 Extends Capital Management Program for 12 Months

27 de ago. de 2025, 22:52 UTC

Ganhos

South32 FY Underlying Ebitda $1.93 Billion, Up 7% On-Year

27 de ago. de 2025, 22:51 UTC

Ganhos

South32 FY Revenue $5.78 Billion, Up 17% On-Year

27 de ago. de 2025, 22:51 UTC

Ganhos

South32 FY Underlying Earnings $666 Million, Up 75% On-Year

27 de ago. de 2025, 22:50 UTC

Ganhos

South32 to Pay Final Dividend of 2.6 U.S. Cents/Share

27 de ago. de 2025, 22:50 UTC

Ganhos

South32 FY Net Profit $213 Million Vs $203 Million Loss Year Earlier

27 de ago. de 2025, 22:45 UTC

Ganhos

Sandfire Resources Expects FY26 Matsa Capital Expenditure of $148 Million

27 de ago. de 2025, 22:44 UTC

Ganhos

Sandfire Resources Expects FY26 Motheo Unit Cost of $44/Ton of Ore Processed

27 de ago. de 2025, 22:44 UTC

Ganhos

Sandfire Resources Expects FY26 Motheo Capital Expenditure of $82 Million

27 de ago. de 2025, 22:43 UTC

Ganhos

Sandfire Resources Expects FY26 Matsa Unit Cost of $86/Ton of Ore Processed

27 de ago. de 2025, 22:43 UTC

Ganhos

Nvidia Breaks Sales Record Despite Chinese Trade Hiccups -- 5th Update

27 de ago. de 2025, 22:42 UTC

Ganhos

Sandfire Resources Expects FY26 Motheo Copper Eq Output to Rise 3% to 61,000 Tons

27 de ago. de 2025, 22:42 UTC

Ganhos

Sandfire Resources Expects FY26 Matsa Copper Eq Output to Rise 2% to 96,000 Tons

27 de ago. de 2025, 22:40 UTC

Ganhos

Sandfire Resources Net Debt $123 Million at June 30

27 de ago. de 2025, 22:40 UTC

Ganhos

Sandfire Resources FY Underlying Ebitda $527.7 Million

Pharmagest Interactive Previsão

Consenso de Avaliação

By TipRanks

0 ratings

0

Comprar

0

Manter

0

Vender

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Pharmagest Interactive

Equasens Société anonyme provides healthcare IT solutions in Europe. The company develops electronic equipment, digital and robotic health, and equipment lease financing solutions. It also offers id., a pharmacy management software suite; id. PATIENT for the exchange of healthcare data; id. VENTE, which facilitates and secures prescription sales; id. COMMANDE, which manages orders and inventory; dispensing robots; Ségur id. services; FARMACLICK, a communication protocol; DIFARM, a modular solution for wholesalers-distributors; and PHARE, a retail management tool. In addition, the company offers patient medication adherence, patient loyalty, point-of-sale commercial performance, piloting pharmacy operations, pharmacy team training, securing pharmacy operations and health data, and digital communication solutions; and in-home nursing services and hospital-at-home, hospitals, and telemedicine solutions. Further, it provides id. DESK, an informative and interactive dashboard; id. UP!, a smartphone app; id. EASYQ, a queuing management solution; Miaterapia, a patient app; and MediStory for tracking patient records; ExpressVitale module; and MEDILINK, a health data hosting provider. Additionally, the company offers KAP&LINK2, a terminal with smart card and NFC reader; eS-KAP-Ad, a mobile device with a pre-loaded software; KAP-INSIDE, a mobile terminal; TI-KAP, which allows access to contact and contactless cards; AUTHENTIFICATEUR, a patented patient authentication system; KAP'TEUR by KAPELSE, a patented universal sensor; and NOVIAcare, which analyzes the behavior and activity of the elderly. It serves nursing homes, hospitals, in-house nursing care and hospital-at-home programs, regional health professional communities, multidisciplinary group practices, and individual healthcare professionals. The company was incorporated in 1996 and is headquartered in Villers-les-Nancy, France. Equasens Société anonyme is a subsidiary of Marque Verte Sante.